Reported about 9 hours ago
President Trump is poised to sign an executive order aimed at reducing prescription drug prices in the U.S. to align with international rates. The order will involve various government agencies, including the USTR and Commerce Department, to tackle discriminatory practices affecting U.S. companies and oversee antitrust investigations. Additionally, the FDA is tasked with facilitating the importation of cheaper pharmaceuticals, and the Health and Human Services department will negotiate to match lower market prices from other countries. However, concerns remain about the feasibility and potential legal challenges surrounding this initiative.
Source: YAHOO